Skip to content

Het Siemens INNOVANCE* PFA P2Y Test Cartridge Project

Het Siemens INNOVANCE* PFA P2Y Test Cartridge Project - Het Siemens INNOVANCE* PFA P2Y Test Cartridge Project

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33130
Enrollment
100
Registered
2009-10-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease - atherosclerosis

Interventions

None listed

Sponsors

Siemens Healthcare Diagnostics
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients must have a history of vascular disease (cardiovascular or cerebrovascular) or at least two of eight risk factors for developing vascular disease based on the following American Heart Association criteria: • current or previous history of smoking • hypertension • hyperlipidemia • family history of vascular disease • post-menopausal females • diabetes mellitus • morbid obesity • sedentary lifestyle Other inclusion criteria • >=18 years of age (18 to 90) • Documented history of vascular disease (cardiovascular or cerebrovascular) or at least two of the risk factors for developing vascular disease described in §3.1 • Eligible to receive clopidogrel • Indication for clopidogrel • Able to provide written, informed consent in accordance with the IRB (internal review board or ethics committee) and agree to comply with all protocol-specified procedures

Exclusion criteria

Exclusion criteria: •

Design outcomes

Secondary

MeasureTime frame
niet nodig

Primary

MeasureTime frame
niet nodig

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)